Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: An autopsy study

Prostate

Volumn 66, Issue 12, 2006, Pages 1319-1328

  Stamatiou, Konstantinos ^a   Alevizos, A ^b   Agapitos, E ^c   Sofras, F ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b Health Center of Vyronas   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atypical adenomatous hyperplasia; Autopsy study; Benign prostate hypertrophy; Impalpable prostate carcinoma; Prostatic intraepithelial neoplasia

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHY; AUTOPSY; CANCER INCIDENCE; CARCINOMA IN SITU; GREECE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROSTATE ATROPHY; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; TUMOR VOLUME; ADENOMATOUS POLYP; AGE; DIGITAL RECTAL EXAMINATION; INCIDENCE; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ADENOMATOUS POLYPS; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATROPHY; AUTOPSY; DIGITAL RECTAL EXAMINATION; GREECE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 33748366812     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20339     Document Type: Article

References (64)

1. Henson DE, Hutter RP, Farrow G. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the cancer Committee, College of American Pathologists. Arch Pathol Lab Med 1994;118:779-783.
2. Sesterhenn IA. Prostate and testis tumor. AFIP genitourinary pathology: WHO classification of tumors pathology and genetics of the tumors of the urinary system and male genital organs. Washington, USA: WHO; 2003.
3. Montironi R, Mazzuccheli R, Kwast T. Morfological assessment of radical prostatectomy specimens. A protocol with clinical relevance. Virch Arch 2003;442:211-217.
4. Bostwick GD. Pathology of the prostate. Boston: Churchill Livingstone, New York, NY, 1990.
5. Epstein JI, Walsh PC, Brendler CB. Radical prostatectomy for impalpable prostate cancer: The Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). J Urol 1994;152(5 Pt 2):1707-1708.
6. Nicolo G, Salvi S, Musso C, Amore E. Latent carcinoma of the prostate. Autopsy study of 100 cases. Patologica 1986;78:579-591.
7. Sánchez-Chapado M, Olmedilla G, Cabeza M, Donat E, Ruiz A. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study. The Prostate 2003;54:238-247.
8. Tiszlavicz L, Szalay I. Multiple urologic tumors in autopsy material. Orv Hetil 1993;134(11):577-581.
9. Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H. Latent carcinoma of prostate at autopsy in seven areas. The International Agency of research on Cancer, Lyons, France. Int J Cancer 1977;20(5):680-688.
10. Harbitz TB, Haugen OA. Histology of the prostate in elderly men: A study in an autopsy series. Acta Pathol Microbiol Scand [A] 1972;80:756-768.
11. Hollund B. Latent prostate cancer in a consecutive autopsy series. Scand J Urol Nerhrol 1980;14(1):29-35.
12. Schutze U. Latent prostatic carcinoma-an autopsy study of men over 50 years of age. Zentralbl Allg Pathol 1984;129(4):357-364.
13. Yatani R, Chigusa I, Akazaki K, Stemmermann GN, Welsh RA, Correa P. Geographic pathology of latent prostatic carcinoma. Int J Cancer 1982;29(6):611-616.
14. Billis A. Latent carcinoma and atypical lesions of prostate. An autopsy study. Urology 1986;28(4):324-329.
15. Hondros N, Tsebisev P, Mavromanolakis E. Prostate carcinoma in cysteoprostatectomy specimens. Clinical importance. 16th Pan-Hellenic urological congress. Abstract, p 75. Kalamata 2002.
16. Suen KC, Lau LL, Yermakov V. Cancer and old age. An autopsy study of 3,535 patients over 65 years old. Cancer 1974;33(4):1164-1168.
17. Takahashi S, Shirai T, Hasegawa R, Imaida K, Ito N. Latent prostatic carcinomas found at autopsy in men over 90 years old. Jpn J Clin Oncol 1992;22(2):117-121.
18. Rullis I, Shaeffer JA, Lilien OM. Incidence of prostatic carcinoma in the elderly. Urology 1975;6(3):295-297.
19. Suen KC, Lau LL, Yermakov V. Cancer and old age. An autopsy study of 3,535 patients over 65 years old. Cancer 1974;33(4):1164-1168.
20. Guileyardo J, Johnson W, Welsh R, Akazaki K, Correa P. Prevalence of latent prostatic carcinoma in two U.S. populations. J Nat Cancer Inst 1980;65:311-316.
21. Muir CS, Nectoux J, Staszewski J. The epidemiology of prostate cancer. Geographical distribution and time-trends. Acta Oncol 1991;30:133-140.
22. Yatani R, Shiraishi T, Makakuki K, Takanari H, Hayashi T, Stemmermann G. Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986. J Natl Cancer Inst 1988;80(9):683-687.
23. Gatling RR. Prostate carcinoma: An autopsy evaluation of the influence of age, tumor grade, and therapy on tumor biology. South Med J 1990;83(7):782-784.
24. Mettlin CJ, Murphy G. The National Cancer Data Base Report on Prostate Cancer. Cancer 1994;74(5):1640(9).
25. Lytton B, Emery JM, Harvard BM. The incidence of benign prostatic hypertrophy. J Urol 1978;99:639-645.
26. Rotkin ID. Epidemiology of benign prostatic hypertrophy: Review and speculations. In: Greyhack JT, Wilson JD, Scherbenski MJ, editors. Benign prostatic hyperplasia. DHEW Publ. (NIH) 76-1113. Washington DC: US Government Printing Office; 1976.
27. Berry S, Coffey D, Walsh P, Ewing L. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-479.
28. Guess HA. The epidemiology and natural history of benign prostatic hyperplasia. In: Chisholm G, editor. Handbook of benign prostatic hyperplasia. New York: Raven Press; 1991.
29. Garraway W, Collins G, Lee R. High prevalence of benign prostatic hyperplasia in the community. Lancet 1991;338:469-715.
30. Shirai T, Takahashi T, Ito S. Nodular hyperplasia and latent carcinoma in autopsy obtained prostate. In: Manual of benign prostatic hyperplasia. Prostatic Research Foundation (ed). Tokyo: Kanehara Shuppan, Inc.; 1990.
31. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992;70(1 Suppl):291-301.
32. Feneley MR, Landis P, Simon I. Today men with prostate cancer have larger prostates. Urology 2000;56:193-196.
33. Matsusima H. Correlation of atypical hyperplasia and latent carcinoma of the prostate. Nippon Hinyokika Gakkai Zasshi 1991;82(11):1821-1828.
34. Sakr WA, Grignon DJ, Haas GP. Pathology of pre-malignant lesions and carcinoma of the prostate in African-American men. Semin Urol Oncol 1998;16(4):214-220.
35. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, Haas GP. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: An autopsy study of 249 cases. In Vivo 1994;8(3):439-443.
36. Puig-Sureda I, Lopez Duesa L, Rodriguez-Vallejo JM, Gonzalez-Esteban J. Relationship of prostatic carcinoma of the peripheral zone with glandular atrophy and prostatic intraepithelial neoplasia. Acta Urol Esp 1997;21(1):40-43.
37. Sanchez Chapado M, Angulo J, Cabeza M, Donat E, Ruiz A, Olmedilla G, Rodriguez Vallejo JM. Prevalence of prostatic intraepithelial neoplasia in Spain. Arch Esp Urol 2001;54(10):1103-1109.
38. Epstein JT, Cho KP, Quinn BD. Correlation between displasia and adenocarcinoma of the prostate stage A. J Hopkins Hospital Baltimore Cancer 1990;65:2321-2327.
39. Alamanis C, Papaducakis S. Epidemiologic, biological, and microscopic parameters of occult prostate adenocarcinoma. 16th Pan-Hellenic Urological Congress. Absract p 74. Kalamata 2002.
40. Bostwick DG, Norlen BG, Denis L. Prostatic intraepithelial neoplasia, the pre-invasive stage of prostate cancer. Scand J Urol Nephrl 2000;(Suppl):1-2.
41. McNeal JE, Bostwick DG. Intraductal dysplasia: A pre-malignant lesion of the prostate. Hum Pathol 1986;17:64-71.
42. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high grade prostatic intraepithelial neoplasia on needle biopsy: Data on men with more than one follow-up biopsy. Am J Surg Pathol 2001;25:1079-1085.
43. Keetch DW, Humphrey P, Stahl D, Smith DS, Catalona WJ. Morphometric analysis and clinical follow-up of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 1995;154:347-351.
44. Kovi J, Mostofi FK, Heshmat MY, Enterline JP. Large acinar atypical hyperplasia and carcinoma of the prostate. Cancer 1988;61555-568.
45. Haggman MJ, Macoska JA, Wojno KJ, Oesterling JE. The relationship between prostatic intraepithelial neoplasia and prostate cancer: Critical issues. J Urol 1997;158:12-22.
46. Epstein JT, Cho KP, Quinn BD. Correlation between displasia and adenocarcinoma of the prostate stage A. J Hopkins Hospital Baltimore Cancer 1990;65:2321-2327.
47. Hoffman L, Putzke HP, Gunther I, Rodewald P, Erdmann T. Relations between atypical hyperplasia and latent carcinoma of the prostate. Z Urol Nephrol 1987;80(10):561-569.
48. Davidson D, Bostwick DG, Qian J. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: Predictive accuracy in needle biopsies. J Urol 1995;154(4):1295-1299.
49. Grignon D, Sakr W. Atypical adenomatous hyperplasia of the prostate: A critical review. Eur Urol 1996;50:125-128.
50. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992;70(1 Suppl):291-301.
51. Di Silverio F, Gentile V, De Matteis A, Mariotti G, Giuseppe V, Luigi PA, Sciarra A. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis. Eur Urol 2003;43(2):164-175.
52. Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH, Bose D, Harrison J, Young RH. Atypical adenomatous hyperplasia of the prostate: Morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol 1993;24(8):819-832.
53. Bostwick DG, Qian J. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol 1995;19(5):506-518.
54. Billis A. Prostatic atrophy: An Autopsy Study of a Histologic Mimic of Adenocarcinoma. Am J Surg Pathol 1999;23:1534-1539.
55. Baron JC, Zerbib M, Leveque JM, Deslignieres S, Boccon-Gibod L, Debre B, Steg A. Detection of a prostatic adenocarcinoma in the cysto-prostatectomy specimens of an invasive tumor of the bladder. Ann Urol 1989;23(2):119-122.
56. Epstein JE. Pathology of adenocarcinoma of the prostate. In Campbell's Urology, 6th edition. Philadelphia: WB Saunders; 1997. p 2497.
57. Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 1994;152(5 Pt 2):1732-1736.
58. Arora R, Koch MO, Eble JN, Ulbright TM, Li L, Cheng L. Heterogeneity of Gleason grade in multi-focal adenocarcinoma of the prostate. Cancer 2004;100(11):2362-2366.
59. Fukagai T, Namiki T, Namiki H, Carlile RG, Shimada M, Yoshida H. Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens. Pathol Int 2001;51(5):364-370.
60. Aihara M, Sheeler TM, Ohori M. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urol 1994;43:60-66.
61. Epstein JI, Steinberg GD. The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade, volume, and stage of the biopsied and multi-focal tumor. Cancer 1990;66(9):1927-1932.
62. Miller GJ, Cygan JM. Morphology of prostate cancer: The effects of multifocality on histological grade, tumor volume and capsule penetration. J Urol 1994;152(5 Pt 2):1709-1713.
63. Newman AJ Jr., Graham MA, Carlton CE Jr., Lieman S. Incidental carcinoma of the prostate at the time of transurethral resection: Importance of evaluating every chip. J Urol 1982;128(5):948-950.
64. Whittemore AS, Keller JB, Betensky R. Low-grade, latent prostate cancer volume: Predictor of clinical cancer incidence? J Natl Cancer Inst 1991;83:1231-1235.